Ya-xian Wu
Wuxi, 214122, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
MOTS-c attenuates hyperoxia-induced neonatal cardiac injury by inhibiting oxeiptosis via maintaining the KEAP1-PGAM5 interaction.
Journal: Life sciences
Published: March 10, 2026
SLC25A28 Ameliorates Hyperoxic Lung Injury by Improving Mitochondrial Oxidative Phosphorylation in Alveolar Epithelial Cells.
Journal: International journal of molecular sciences
Published: March 09, 2026
Mitochondria-derived peptide MOTS-c alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice by activating Nrf2 pathway.
Journal: European journal of pharmacology
Published: August 11, 2025
MOTS‑c protects against placental injury via Nrf2 activation in hypoxia‑induced intrauterine growth restriction mice.
Journal: International journal of molecular medicine
Published: May 09, 2025
Preconception maternal hyperoxia exposure causes cardiac insufficiency through induction of mitochondrial toxicity in mice offspring.
Journal: Reproductive toxicology (Elmsford, N.Y.)
Published: September 18, 2024
Nrf2 deficiency exacerbated pulmonary pyroptosis in maternal hypoxia-induced intrauterine growth restriction offspring mice.
Journal: Reproductive toxicology (Elmsford, N.Y.)
Published: May 20, 2024
BCL6 attenuates hyperoxia-induced lung injury by inhibiting NLRP3-mediated inflammation in fetal mouse.
Journal: Experimental lung research
Published: February 29, 2024
4-OI ameliorates bleomycin-induced pulmonary fibrosis by activating Nrf2 and suppressing macrophage-mediated epithelial-mesenchymal transition.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: February 02, 2023
Maternal propionate supplementation ameliorates glucose and lipid metabolic disturbance in hypoxia-induced fetal growth restriction.
Journal: Food & function
Published: September 30, 2022
Last Updated: 09/26/2026